comparemela.com

Latest Breaking News On - லாரன்ஸ் ஸ்டெய்ன்மேன் - Page 6 : comparemela.com

Medivolve Announces Closing of Bought Deal Private Placement

Medivolve Announces Closing of Bought Deal Private Placement January 26, 2021 09:07 ET | Source: Medivolve Inc. Medivolve Inc. Montreal, Quebec, CANADA THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 26, 2021 (GLOBE NEWSWIRE)  Medivolve Inc. (“ Medivolve” or the “ Company”) (NEO:MEDV; FRA:34C1) is pleased to announce that it has closed the previously announced bought deal private placement of an aggregate of 20,000,000 units (the “ Units”) at a price per Unit of $0.25 (the “ Issue Price”) for aggregate gross proceeds to the Company of $5,000,000 (the “ Offering”). Canaccord Genuity Corp. (“ Each Unit consists of one common share of the Company (a

Collection Sites Announces Partnership with Health and Wellness Expert, Heidi Powell

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Collection Sites Announces Partnership with Health and Wellness Expert, Heidi Powell Medivolve Inc.January 21, 2021 GMT TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) Medivolve, Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of a partnership between its wholly owned subsidiary, Collection Sites, LLC, and Heidi Powell, fitness and transformation expert from ABC’s ‘Extreme Weight Loss’ show. Furthering its dedication to flatten the curve against the novel coronavirus, Collection Sites and Heidi Powell have launched two COVID-19 testing centers in Austin, Texas and Tempe, Arizona providing convenient access to rapid antibody and antigen tests. As part of the partnership, Heidi Powell has paid an upfront fee to launch the test centre in exchange for a small royalty. Through this partnership, Collection Sites customers nationwide will have access to H

Collection Sites Achieves Expansion into State of Texas with Launch of 4 New COVID-19 Testing Sites The continued success of Collection Sites rollout has led to the expansion into Texas, with 4 sites now operating across the state for a total of 46 operating sites

TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of five new COVID-19…

Collection Sites Achieves Expansion into State of Texas with Launch of 4 New COVID-19 Testing Sites

Collection Sites Achieves Expansion into State of Texas with Launch of 4 New COVID-19 Testing Sites The continued success of Collection Sites rollout has led to the expansion into Texas, with 4 sites now operating across the state for a total of 46 operating sites. January 19, 2021 07:30 ET | Source: Medivolve Inc. Medivolve Inc. TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of five new COVID-19 testing centres in Texas by its wholly owned subsidiary, Collection Sites, LLC. The sites are located in or close to the Austin and Fort Worth urban centres.

Collection Sites Achieves Expansion into State of Pennsylvania with Launch of 5 New COVID-19

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Collection Sites Achieves Expansion into State of Pennsylvania with Launch of 5 New COVID-19 . Medivolve Inc.January 14, 2021 GMT The continued success of Collection Sites rollout has led to the expansion into Pennsylvania, with 5 sites now operating across the state for a total of 40 operating sites. TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:34C1) is pleased to announce the launch of five new COVID-19 testing centres in Pennsylvania by its wholly owned subsidiary, Collection Sites, LLC. With individual sites currently achieving strong sales with 7-day rolling average of 75 tests per day and average test price exceeding US$95 per test, these five sites are expected to add substantively to Medivolve’s top-line revenue.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.